Limited evidence exists on the use of FGM in people with type 2 diabetes (T2D) on non-prandial insulin therapies.

Aim: To study the feasibility of intermittent FGM and education among sub-optimally controlled T2D. Adult T2Ds on any treatment but prandial insulin, HbA1c 7.5-10%, received Freestyle Libre sensor and structured education. Sensor use was continuous for 6 weeks (w), then 2 weekly up to 24w. A blinded sensor was worn at -2w and 24w. n=28, 11 men, mean age 55± 12 y, BMI 27.2 ± 4 kg/m2, 6/28 on basal insulin. Mean HbA1c fell from baseline of 8.5 ± 0.5% to 7.9 ± 0.9% (69 to 63 mmol/mol, p=0.001) and was sustained to 24w (fig 1). SD and TAR (>13.9 mmol/L) showed a trend to improvement (Table 1). Intermittent FGM use with education in T2D showed a sustained improvement in glycemia up to 24 weeks.


S. Rama Chandran: None. M. Gandhi: None. K. Adaikan: None. N. Tan: None. I.K.Y. Phoon: None. D. Gardner: None.


Singapore Ministry of Health (MH34:31/2)

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at